Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

NCT00676507 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

532

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Neoplasm
Carcinoma Non-small Cell Lung Cancer Stage IIIA
Carcinoma Non-small Cell Lung Cancer Stage IIIB
Carcinoma Non-small Cell Lung Cancer Stage IV

Interventions

BIOLOGICAL: Lucanix™
OTHER: Placebo Comparator

Sponsor

NovaRx Corporation